These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3053942)

  • 21. Use of extract of Ruscus aculeatus in venous disease in the lower limbs.
    Cappelli R; Nicora M; Di Perri T
    Drugs Exp Clin Res; 1988; 14(4):277-83. PubMed ID: 3048951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vital capillaroscopy on microcirculation: pharmacodynamic activity of Daflon 500 mg in venous insufficiency.
    Balas P; Pagratis N
    Int Angiol; 1989; 8(4 Suppl):51-2. PubMed ID: 2632650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. At the crossroads of venous insufficiency and hemorrhoidal disease: Daflon 500 mg--repercussions of venous insufficiency on everyday life.
    Launois R
    Angiology; 1994 Jun; 45(6 Pt 2):495-504. PubMed ID: 8203779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daflon 500 mg in the treatment of hemorrhoidal disease: a demonstrated efficacy in comparison with placebo.
    Godeberge P
    Angiology; 1994 Jun; 45(6 Pt 2):574-8. PubMed ID: 8203790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Derivatives of semi-synthetic diosmine in the treatment of patients with chronic venous insufficiency. The results of a prospective study--using phlebodia 600].
    Pokrovskiĭ AV; Sapelkin SV
    Angiol Sosud Khir; 2005; 11(4):73-9. PubMed ID: 16474293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic effectiveness of flavonoids illustrated by daflon 500 mg].
    Hitzenberger G
    Wien Med Wochenschr; 1997; 147(18):409-12. PubMed ID: 9454438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency.
    Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Di Renzo A; Ruffini I; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cornelli U; Hosoi M; Cacchio M
    Angiology; 2006; 57(2):131-8. PubMed ID: 16518519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From symptoms to leg edema: efficacy of Daflon 500 mg.
    Nicolaides AN
    Angiology; 2003; 54 Suppl 1():S33-44. PubMed ID: 12934755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Semisynthetic Diosmin (Phlebodia 600) for therapy of lower limb chronic venous insufficiency].
    Kirienko AI; Bogachev VIu; Zolotukhin IA; Golovanova OV
    Angiol Sosud Khir; 2006; 12(2):73-5. PubMed ID: 17053765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daflon 500 mg: symptoms and edema clinical update.
    Ramelet AA
    Angiology; 2005; 56 Suppl 1():S25-32. PubMed ID: 16193223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency.
    Boyle P; Diehm C; Robertson C
    Int Angiol; 2003 Sep; 22(3):250-62. PubMed ID: 14612852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of haemorheological and microcirculatory disturbances in chronic venous insufficiency: activity of Daflon 500 mg.
    Le Dévéhat C; Khodabandehlou T; Vimeux M; Kempf C
    Int J Microcirc Clin Exp; 1997; 17 Suppl 1():27-33. PubMed ID: 9477042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy of micronized purified flavonoid fraction: an overview.
    Struckmann JR
    J Vasc Res; 1999; 36 Suppl 1():37-41. PubMed ID: 10474049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and hemodynamic outcomes in patients with chronic venous insufficiency after oral micronized flavonoid therapy.
    Ting AC; Cheng SW; Wu LL; Cheung GC
    Vasc Surg; 2001; 35(6):443-7. PubMed ID: 16222383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk factors of chronic venous insufficiency of the lower extremities and possibilities of its medication in therapeutic practice].
    Oganov RG; Savel'ev VS; Shal'nova SA; Kirienko AI; Zolotukhin IA
    Ter Arkh; 2006; 78(4):68-72. PubMed ID: 16821427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemorheological improvement after Daflon 500 mg treatment in diabetes.
    Lacombe C; Bucherer C; Lelievre JC
    Int Angiol; 1988; 7(2 Suppl):21-4. PubMed ID: 3183453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of micronized purified flavonoid fraction (MPFF) in edema.
    Olszewski W
    Angiology; 2000 Jan; 51(1):25-9. PubMed ID: 10667640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings.
    Unkauf M; Rehn D; Klinger J; de la Motte S; Grossmann K
    Arzneimittelforschung; 1996 May; 46(5):478-82. PubMed ID: 8737630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RELIEF study: first consolidated European data. Reflux assEssment and quaLity of lIfe improvement with micronized Flavonoids.
    Jantet G
    Angiology; 2000 Jan; 51(1):31-7. PubMed ID: 10667641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients.
    Guilhou JJ; Dereure O; Marzin L; Ouvry P; Zuccarelli F; Debure C; Van Landuyt H; Gillet-Terver MN; Guillot B; Levesque H; Mignot J; Pillion G; Février B; Dubeaux D
    Angiology; 1997 Jan; 48(1):77-85. PubMed ID: 8995348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.